Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
Ilias D. Vachliotis, Stergios A. Pοlyzos
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 191-206
Open Access | Times Cited: 44
Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
Yuan Zeng, Yifan Wu, Qian Zhang, et al.
mBio (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 33
The interplay of gut microbiota, obesity, and depression: insights and interventions
Iryna Halabitska, Pavlo Petakh, Iryna Kamyshna, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Closed Access | Times Cited: 10
Anti-hepatopathy and anti-nephropathy activities of Taraxacum officinale in a rat model of Streptozotocin diabetes-induced hepatorenal toxicity and dyslipidemia via attenuation of oxidative stress, inflammation, apoptosis, electrolyte imbalances, and mitochondrial dysfunction
Sunday Aderemi Adelakun, Aniah Julius Akomaye, O Omotoso, et al.
Aspects of Molecular Medicine (2024) Vol. 3, pp. 100034-100034
Open Access | Times Cited: 6
Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes
Sabrina Donati Zeppa, Marco Gervasi, Alessia Bartolacci, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3951-3951
Open Access | Times Cited: 5
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
Ahmad Moolla, Toryn Poolman, Nantia Othonos, et al.
JHEP Reports (2025) Vol. 7, Iss. 5, pp. 101363-101363
Open Access
The therapeutic success of approaches to the gastrointestinal microbiome modulation in the treatment of obesity, metabolic syndrome and type 2 diabetes mellitus
Anastasia A. Zabolotneva, О. П. Шатова, J. A. Agapova, et al.
Diabetes Mellitus (2025) Vol. 27, Iss. 6, pp. 598-610
Open Access
The effect of GLP‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis
Yifan Ren, Yuzhang Chen, Wenbin Zheng, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
Vincenzo Trapanese, A W D'agostino, Maria Resilde Natale, et al.
Life (2025) Vol. 15, Iss. 6, pp. 843-843
Open Access
Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives
Georgiana-Diana Cazac, C.M. Lǎcǎtusu, Gabriela Ștefănescu, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 581-581
Open Access | Times Cited: 7
Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy
Diego Añazco, Andrés Acosta
International Journal of Obesity (2024)
Closed Access | Times Cited: 2
Leveraging metabolism for better outcomes in heart failure
Yann Huey Ng, Yen Chin Koay, Francine Z. Marques, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 15, pp. 1835-1850
Open Access | Times Cited: 2
Comparison of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter protein-2 inhibitors on treating metabolic dysfunction-associated steatotic liver disease or metabolic dysfunction-associated steatohepatitis: systematic review and network meta-analysis of randomised controlled trials
Ruhan Xu, Bo Liu, Xianghai Zhou
Endocrine Practice (2024)
Closed Access | Times Cited: 2
Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma
Ilias D. Vachliotis, Ioannis Valsamidis, Stergios A. Pοlyzos
Cancers (2023) Vol. 15, Iss. 21, pp. 5306-5306
Open Access | Times Cited: 5
Liraglutide ameliorates diabetic kidney disease by modulating gut microbiota and L-5-Oxoproline
Bo Yi, Ke Su, Yuli Cai, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176905-176905
Closed Access | Times Cited: 1
Pharmacological methods for weight reduction and their connection with the human gut microbiota
Venelin Dimitrov Denchev, Teodora Handjieva‐Darlenska
Pharmacia (2023) Vol. 70, Iss. 4, pp. 1471-1477
Open Access | Times Cited: 1
Identification of a novel hypoglycemic small molecule, trans-2, 4-dimethoxystilbene by rectifying gut microbiota and activating hepatic AMPKα-PPARγ pathway through gut-liver axis
Zijing Wang, Peng Ma, Chunyang Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116760-116760
Open Access
Experimental colonization with H. hepaticus, S. aureus and R. pneumotropicus does not influence the metabolic response to high-fat diet or incretin-analogues in wildtype SOPF mice
M Wunderlich, Manuel Miller, Bärbel Ritter, et al.
Molecular Metabolism (2024) Vol. 87, pp. 101992-101992
Open Access
Rebalancing the Gut: Glucagon-Like Peptide-1 Agonists as a Strategy for Obesity and Metabolic Health
K. Singh, Smriti K Aulakh, G. S. Nijjar, et al.
Cureus (2024)
Open Access
GLP-1RAs attenuated obesity and reversed leptin resistance partly via activating the microbiome-derived inosine/A2A pathway
Chunyan Dong, Bailing Zhou, Binyan Zhao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 1023-1038
Open Access
Akkermansia muciniphila: A Potential Target for the Prevention of Diabetes
Kairu He, Feiyu An, Henan Zhang, et al.
Foods (2024) Vol. 14, Iss. 1, pp. 23-23
Open Access
Microbial perspective of multidisciplinary collaborative weight management approach: Ruminococcus gnavus may serve as a key target for weight loss
Sijia Zhao, Wenjun Wu, Wenyan Song, et al.
Gut Microbes (2024) Vol. 17, Iss. 1
Open Access
Page 1

Scroll to top